About Dupen Laboratories
Dupen Laboratories was a Healthcare company based in Mumbai (India) founded in 1971. It manufactures and markets its own pharmaceutical brands while providing CMO services. It operates on a B2B model. The company has 6 employees. Its Indian entity Dupen Laboratories Private Limited reported revenue of ₹8.20 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Manufacturing and Brand Marketing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Dupen Laboratories, established in 1971 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and brand marketing. Manufactures and markets its own pharmaceutical brands while providing CMO services. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Mumbai, India
- Employees 6
- SectorsHealthcare
- Website ww7.dupenlabs.com
- Legal Name Dupen Laboratories Private Limited
- Date of Incorporation 23 Mar, 1976
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹8.20 Cr
FY 2025 · -35% YoY
- Net Loss-₹63.7 Lakh
FY 2025 · -8% margin
- EBITDA-₹49.4 Lakh
FY 2025 · -6% margin
- Employee Count6
Associated legal entities of Dupen Laboratories
Dupen Laboratories operates through Dupen Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dupen Laboratories Private Limited CIN U24239MH1976PTC103955 | Active | 23 Mar 1976 | Mumbai, Maharashtra | ₹8.2 Cr | 6 | 3 | View details |
Board of directors of Dupen Laboratories Private Limited (Dupen Laboratories)
Dupen Laboratories Private Limited is the primary company behind Dupen Laboratories. The board of Dupen Laboratories Private Limited currently have 3 directors; the longest-serving is Rajeshwari Datla, appointed in 1995. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajeshwari Datla DIN 00046864 | Managing Director | 01 Jan 1995 | 31 yrs 9 mo | Dupen Laboratories Private Limited |
| Anupama Datla Desai DIN 00217027 | Director | 15 Dec 2004 | 21 yrs 10 mo | Dupen Laboratories Private Limited |
| Nagendra Varaprasad Nadimpally DIN 00217210 | Whole-time director | 01 Jan 2017 | 9 yrs 10 mo | Dupen Laboratories Private Limited |
Financials of Dupen Laboratories
Figures of Dupen Laboratories Private Limited, the primary company behind Dupen Laboratories, for FY 2025. Revenue was ₹8.20 Cr (-35% year on year). Net loss was -₹63.7 Lakh (-8% margin). EBITDA was -₹49.4 Lakh (-6% margin). Revenue has grown at a compounded annual rate of -25% over three years and -13% over five years.
- ₹8.20 CrRevenue · FY 2025 · -35% YoY
- -₹63.7 LakhNet loss · -8% margin
- -₹49.4 LakhEBITDA · -6% margin
- ₹9.9 LakhPaid-up capital
- 6Employees (provident fund records)
- -25%Revenue CAGR, 3 years
- -13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Dupen Laboratories Private Limited are on its company page.
Detailed financial statements for Dupen Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Dupen Laboratories
Dupen Laboratories has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Dupen Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dupen Laboratories
Dupen Laboratories was founded in 1971.
Dupen Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Dupen Laboratories has 6 employees.
The primary company behind Dupen Laboratories, Dupen Laboratories Private Limited, reported revenue of ₹8.20 Cr for FY 2025, down 35% year on year.
Dupen Laboratories, established in 1971 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and brand marketing. Manufactures and markets its own pharmaceutical brands while providing CMO services. Adapting to market demands with innovation and client-focused strategies.
Dupen Laboratories's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Dupen Laboratories operates through Dupen Laboratories Private Limited.
The legal entities of Dupen Laboratories currently have 3 directors, including Rajeshwari Datla, Nagendra Varaprasad Nadimpally, Anupama Datla Desai.